Upregulation of Pluripotency Markers in Adipose Tissue-Derived Stem Cells by miR-302 and Leukemia Inhibitory Factor
Figure 4
(a) Immunostaining of the freshly isolated ADSCs (ADSC P0) with anti-Sox2 monoclonal antibody, (b) propidium iodide (PI) staining of the nuclei represented in (a), (c) immunostaining of the third-passaged ADSCs (ADSC P3) with anti-Sox2 antibody, and (d) PI staining of the nuclei represented in (f).
